# 🧪 Phosphorus Disorders Reference Center

## ![Kidney](https://urinenephrology.org/2025_UDPA_Lectures_Live/assets/Kidney_image.png) Calcium-Phosphate Homeostasis System

Interactive diagram showing phosphate regulation via FGF23-Klotho axis, PTH, and calcitriol pathways

**🔑 Key Concept:** Phosphate homeostasis involves the critical FGF23-Klotho axis (primarily from kidneys) working with PTH and calcitriol. Note the inverse Ca-PO₄ relationship and the central role of kidneys in both excretion and hormone production.

## 🎯 Phosphorus Quick Reference

Normal Range: 2.5-4.5 mg/dL (0.81-1.45 mmol/L)

Critical for: ATP synthesis, bone mineralization, cellular signaling

## 📊 Phosphorus Distribution & Physiology

#### Total Body Phosphorus

~700g

Adult human body

#### Skeletal System

85%

As hydroxyapatite

#### Soft Tissues

14%

Intracellular (ATP, DNA)

#### Extracellular

1%

Measured serum level

### Key Physiologic Roles

- **Energy Metabolism:** ATP, ADP, AMP, creatine phosphate
- **Cellular Signaling:** Protein phosphorylation, second messengers
- **Structural:** DNA, RNA, phospholipid membranes
- **Bone Mineralization:** Hydroxyapatite Ca₁₀(PO₄)₆(OH)₂
- **Acid-Base Buffer:** HPO₄²⁻/H₂PO₄⁻ system
- **Oxygen Delivery:** 2,3-DPG in RBCs

## 🔄 Phosphate Regulation System

### Primary Regulators

[TABLE]

### Phosphate Reabsorption Sites

**Proximal Tubule: 80-90%** (via NaPi-2a, NaPi-2c)

**Distal Tubule: 10-20%**

PTH & FGF23 → ↓ NaPi transporters → phosphaturia

## 📉 Hypophosphatemia Overview

**PO₄ \< 2.5 mg/dL**

### Severity Classification

- **Mild:** 2.0-2.5 mg/dL
- **Moderate:** 1.0-2.0 mg/dL
- **Severe:** \<1.0 mg/dL (life-threatening)

### Key Causes

- **Redistribution:** Refeeding syndrome (!), insulin, respiratory alkalosis
- **↓ GI Absorption:** Malabsorption, antacids, vitamin D deficiency
- **↑ Renal Loss:** Hyperparathyroidism, Fanconi syndrome
- **Other:** CRRT, hungry bone syndrome, DKA treatment

### Clinical Manifestations

- **Muscular:** Weakness, rhabdomyolysis
- **Neurologic:** Altered mental status, seizures
- **Hematologic:** Hemolysis, impaired WBC function
- **Respiratory:** Failure (diaphragm weakness)
- **Cardiac:** Cardiomyopathy

## 📈 Hyperphosphatemia Overview

**PO₄ \> 4.5 mg/dL**

### Key Causes

- **↓ Renal Excretion:** CKD (most common), AKI
- **↑ Cellular Release:** Tumor lysis, rhabdomyolysis
- **↑ Intake/Absorption:** Phosphate enemas, vitamin D excess
- **Endocrine:** Hypoparathyroidism, acromegaly
- **Pseudohyperphosphatemia:** Paraproteinemia, hyperlipidemia

### Clinical Consequences

- **Acute:** Hypocalcemia (precipitation)
- **Chronic (CKD-MBD):**
  - Vascular calcification
  - Secondary hyperparathyroidism
  - Renal osteodystrophy
  - Calciphylaxis

## ⚠️ REFEEDING SYNDROME - Critical Alert

Life-threatening phosphate depletion with refeeding after starvation

### High-Risk Patients:

- BMI \<16 kg/m²
- Unintentional weight loss \>15% in 3-6 months
- Little/no nutrition for \>10 days
- Low baseline K⁺, PO₄, or Mg²⁺
- Chronic alcoholism, anorexia nervosa

### Prevention Protocol:

**1. Check baseline:** PO₄, K⁺, Mg²⁺ before feeding **2. Start low:** 10-20 kcal/kg/day initially **3. Supplement:** Thiamine 100mg IV before feeding, then electrolytes **4. Monitor:** Daily electrolytes × 3-5 days **5. Advance slowly:** Increase calories by 20% q2-3 days

## 🦴 CKD-Mineral Bone Disease (CKD-MBD)

The central role of phosphate retention in CKD complications

### Pathophysiology Cascade:

1.  ↓ GFR → Phosphate retention
2.  ↑ FGF23 (earliest change)
3.  ↓ Calcitriol synthesis
4.  ↓ Calcium absorption → hypocalcemia
5.  ↑ PTH (secondary hyperparathyroidism)
6.  Bone disease + vascular calcification

### Calcium-Phosphate Product

**Ca × PO₄ \< 55 mg²/dL²**

Higher values → metastatic calcification risk

## 💊 Phosphate Binder Comparison

[TABLE]

**Clinical Pearl:** Take binders WITH meals (bind dietary phosphate). Separate from other medications by ≥1 hour.

## 📋 Phosphate Replacement Protocols

### IV Phosphate Replacement (for PO₄ \<2.0 mg/dL)

| Serum PO₄     | IV Dose           | Rate            |
|---------------|-------------------|-----------------|
| 1.5-2.0 mg/dL | 0.16-0.32 mmol/kg | Over 4-6 hours  |
| 1.0-1.5 mg/dL | 0.32-0.64 mmol/kg | Over 6-8 hours  |
| \<1.0 mg/dL   | 0.64-1.0 mmol/kg  | Over 8-12 hours |

**⚠️ Maximum rate:** 7 mmol/hour to avoid hypocalcemia/tetany

**Preparations:** K-Phos (K⁺ 4.4 mEq/mmol PO₄) or Na-Phos (Na⁺ 4.0 mEq/mmol PO₄)

### Oral Replacement (for PO₄ \>2.0 mg/dL)

- **Mild deficiency:** 30-60 mmol/day divided TID-QID
- **Options:** K-Phos, Neutra-Phos, milk (1 mmol/30 mL)
- **Side effect:** Diarrhea (osmotic)

## 💡 High-Yield Clinical Pearls

- [x] **Refeeding syndrome** - Most dangerous cause of hypophosphatemia
- [x] **Respiratory alkalosis** - Causes acute intracellular shift of PO₄
- [x] **CKD is \#1 cause** of chronic hyperphosphatemia
- [x] **FGF23 rises first** in CKD, before PTH or phosphate
- [x] **Ca × PO₄ product \>55** = Metastatic calcification risk
- [x] **Phosphate binders WITH meals** - Bind dietary phosphate
- [x] **IV phosphate can cause** hypocalcemia, give slowly
- [x] **Tumor lysis syndrome** - Massive PO₄ release, treat with rasburicase
- [x] **Vitamin D increases** both Ca AND PO₄ absorption
- [x] **PTH paradox** - ↑PTH but ↑PO₄ in CKD (kidney can't excrete)
- [x] **Hidden phosphate** - Processed foods, dark sodas (phosphoric acid)
- [x] **Hungry bone syndrome** - Post-parathyroidectomy PO₄ drops

## 📋 Quick Reference Values

| Parameter        | Normal Range     | Critical Values              |
|------------------|------------------|------------------------------|
| Serum Phosphate  | 2.5-4.5 mg/dL    | \<1.0 or \>7.0 mg/dL         |
| 24hr Urine PO₄   | 400-1300 mg/day  | Varies with diet             |
| FGF23            | \<50 RU/mL       | ↑↑ in CKD                    |
| PTH (with PO₄)   | 15-65 pg/mL      | ↑ with hyperPO₄ in CKD       |
| Ca × PO₄ Product | \<55 mg²/dL²     | \>70 high calcification risk |
| Dietary PO₄      | 1000-1500 mg/day | Restrict to 800-1000 in CKD  |

## 🔗 Calcium-Phosphate Interactions

### Inverse Relationship

- **PTH effect:** ↑ Ca reabsorption but ↓ PO₄ reabsorption
- **Precipitation:** High Ca × PO₄ → tissue deposition
- **Vitamin D:** ↑ BOTH Ca and PO₄ absorption
- **FGF23:** ↓ PO₄ and ↓ calcitriol (indirect ↓ Ca)

### Clinical Implications

- **Acute hyperPO₄** → Hypocalcemia (precipitation)
- **CKD:** ↑ PO₄ drives secondary hyperparathyroidism
- **Post-parathyroidectomy:** Both Ca and PO₄ drop (hungry bone)
- **Vitamin D therapy:** Monitor BOTH Ca and PO₄

📚 For Educational Purposes Only

© 2025 Andrew Bland MD - All Rights Reserved


---

[Website version](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/phosphorus/index.html) · Markdown synchronized October 3, 2026.